BioCatalyst

ZP5-9676 600 mg dose — catalyst calendar

1 verified catalyst event(s) referencing ZP5-9676 600 mg dose, each linked to its official source. Verified as of 2026-11-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-01
in 4mo
ESTIMATED
 READOUT
Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlle
Phase 3 · Soil-Transmitted Helminthiasis (STH)
 Zero Point Five Therapeutics ZP5-9676 600 mg dose ClinicalTrials.gov ↗
✓ Source-checked 2026-11-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.